Wagner G, Briel D
Pharmazie. 1981 Jun;36(6):400-2.
Because of the described immunosuppressive potency of 1-aminoadamantan, the authors prepared conjugates of N-substituted 1-aminoadamantan derivatives with human serum albumin (HSA) and bovine gamma globulin (BGG). To achieve covalent binding of 1-aminoadamantan (1) to HSA and BGG (following the isothiocyanate procedure), 1 was converted to the N-(p-isothiocyanatobenzoyl) derivative of 1-aminoadamantan (4) via the nitro compound (2) and the amino compound (3). The reaction of 4 with HSA and BGG yielded conjugates with thiourea structure. The imidic acid ester hydrochloride (7) and the thioimidic acid ester hydrochloride (11) were prepared from the N-(p-cyanobenzoyl) derivative of 1-aminoadamantan (6) and reacted with HSA and BGG to give conjugates with amidine structure.
鉴于所描述的1-氨基金刚烷的免疫抑制效力,作者制备了N-取代的1-氨基金刚烷衍生物与人血清白蛋白(HSA)和牛γ球蛋白(BGG)的缀合物。为了实现1-氨基金刚烷(1)与HSA和BGG的共价结合(采用异硫氰酸酯法),1通过硝基化合物(2)和氨基化合物(3)转化为1-氨基金刚烷的N-(对异硫氰酸苯甲酰基)衍生物(4)。4与HSA和BGG的反应产生了具有硫脲结构的缀合物。亚氨酸酯盐酸盐(7)和硫代亚氨酸酯盐酸盐(11)由1-氨基金刚烷的N-(对氰基苯甲酰基)衍生物(6)制备,并与HSA和BGG反应,得到具有脒结构的缀合物。